References
- Moran AP. Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol 1996; 31: 22–31, Suppl 215
- Nardone G, D'Armiento F, Corso G, Coscione P, Esposito M, Budillon G. Lipids of human gastric mucosa: effect of Helicobacter pylori infection and nonalcoholic cirrhosis. Gastroenterology 1994; 107: 362–8
- Langton SR, Cesareo SD. Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production. J Clin Pathol 1992; 45: 221–4
- Berstad K, Berstad A, Sjödahl R, Weberg R, Berstad A. Eosinophil cationic protein and phospholipase A2 activity in human gastric juice. Scand J Gastroenterol 1992; 27: 1011–17
- Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995; 57: 565–83
- Goggin P, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC. Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology 1992; 103: 1486–90
- Go MF, Lew GM, Lichtenberger LM, Genta RM, Graham DY. Gastric mucosal hydrophobicity and Helicobacter pylori: response to antimicrobial therapy. Am J Gastroenterol 1993; 88: 1362–5
- Hills BA. Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. Gut 1993; 34: 588–93
- Nilius M, Malfertheiner P. Helicobacter pylori enzymes. Aliment Pharmacol Ther 1996; 10: 65–71, Suppl 1